
Amryt Pharma Holdings Ltd
LSE:AMYT

Fundamental Analysis


Revenue & Expenses Breakdown
Amryt Pharma Holdings Ltd
Balance Sheet Decomposition
Amryt Pharma Holdings Ltd
Current Assets | 276.8m |
Cash & Short-Term Investments | 123.2m |
Receivables | 52.8m |
Other Current Assets | 100.8m |
Non-Current Assets | 578.7m |
PP&E | 8.4m |
Intangibles | 488.7m |
Other Non-Current Assets | 81.5m |
Free Cash Flow Analysis
Amryt Pharma Holdings Ltd
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Amryt Pharma Holdings Ltd
Revenue
|
210.2m
USD
|
Cost of Revenue
|
-106.8m
USD
|
Gross Profit
|
103.4m
USD
|
Operating Expenses
|
-126.8m
USD
|
Operating Income
|
-23.3m
USD
|
Other Expenses
|
-64.2m
USD
|
Net Income
|
-87.5m
USD
|
AMYT Profitability Score
Profitability Due Diligence
Amryt Pharma Holdings Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Score
Amryt Pharma Holdings Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
AMYT Solvency Score
Solvency Due Diligence
Amryt Pharma Holdings Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Score
Amryt Pharma Holdings Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMYT Price Targets Summary
Amryt Pharma Holdings Ltd
Dividends
Current shareholder yield for AMYT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?